Neil W. Peterson - 26 Feb 2026 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Brian G.Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
26 Feb 2026
Net transactions value
-$472,879
Form type
4
Filing time
02 Mar 2026, 14:03:06 UTC
Previous filing
08 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Peterson Neil W. CHIEF OPERATING OFFICER 1600 W MERIT PARKWAY, SOUTH JORDAN /s/ Brian G.Lloyd, Attorney-in-Fact 02 Mar 2026 0001926221

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Award $0 +7,690 +27% $0.000000 36,059 26 Feb 2026 Direct F1
transaction MMSI Common Stock, No Par Value Award $0 +17,002 +47% $0.000000 53,061 26 Feb 2026 Direct F2
transaction MMSI Common Stock, No Par Value Tax liability $472,879 -6,061 -11% $78.02 47,000 26 Feb 2026 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MMSI Non-qualified stock options (right to buy) 25,000 26 Feb 2026 Common Stock 25,000 $68.33 Direct F4
holding MMSI Non-qualified stock options (right to buy) 13,576 26 Feb 2026 Common Stock 13,576 $70.58 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
F2 These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/28/2023.
F3 The Reporting Person surrendered 6,061 shares of common stock to the Issuer for payroll and income taxes. No shares were sold in the open market.
F4 Becomes exercisable in equal annual installments of 25% commencing 08/19/2022.
F5 Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.